Monistat

Inflammation, Tinea Pedis, Dermatophytosis + 20 more
Treatment
20 Active Studies for Monistat

What is Monistat

MiconazoleThe Generic name of this drug
Treatment SummaryMiconazole is an antifungal medication used to treat fungal infections, like yeast infections. It is available as a variety of creams, gels, tablets, and suppositories. Miconazole was first approved by the FDA in 1974 and is still widely used today. Although it has been around for a long time, it has not developed much resistance among the organisms it fights.
SUNMARK MICONAZOLE NITRATE antifungalis the brand name
image of different drug pills on a surface
Monistat Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
SUNMARK MICONAZOLE NITRATE antifungal
Miconazole
1991
255

Effectiveness

How Monistat Affects PatientsMiconazole is an antifungal medication that works by preventing the growth of certain types of fungi. Since it is usually applied to the skin, the majority of the side effects are related to allergies. For intravaginal (inside the vagina) use, patients should not use tampons at the same time and should use another form of contraception to prevent pregnancy and sexually transmitted infections.
How Monistat works in the bodyMiconazole is an antifungal medication used to treat Candida infections. It works in three main ways. First, it stops the Candida cells from producing a certain type of molecule called ergosterol, which is important for the cell's structure and function. Second, it increases the production of substances called reactive oxygen species (ROS) inside the cells, which can lead to cell death. Third, it causes Candida cells to produce more of a molecule called farnesol, which prevents them from forming biofilms that are resistant to antibiotics. It also blocks certain "pumps" inside Candida cells that

When to interrupt dosage

The recommended dosage of Monistat is contingent upon the diagnosed affliction, such as Gastrointestinal candidiasis, Nail candida and Infection, Mixed. The amount of dosage can be found in the table below, reliant upon the mode of delivery (e.g. Topical or Aerosol, spray - Topical).
Condition
Dosage
Administration
Arthrodermataceae
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Yeast Infection
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
cutaneous candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Dermatitis, Seborrheic
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Oropharyngeal Candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Tinea Cruris
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Ringworm
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Tinea
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Dermatitis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Acne Vulgaris
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Inflammation
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Tinea Pedis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Dermatophytosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Candidiasis, Vulvovaginal
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Onychomycosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Cellulitis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Coinfection
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Hyperhidrosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical
Intertrigo
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository, Tincture, Tincture - Topical, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder - Topical, Aerosol, powder, Insert, Suppository - Vaginal, Aerosol, Aerosol - Topical, Capsule; Cream; Kit, Oral; Topical, Capsule; Cream; Kit - Oral; Topical, Cream; Insert, Cream; Suppository, Topical; Vaginal, Tablet, Tablet - Buccal, Buccal, Kit - Vaginal, Insert - Vaginal, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Paste - Topical, Kit - Topical

Warnings

Monistat Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Miconazole may interact with Pulse Frequency
There are 20 known major drug interactions with Monistat.
Common Monistat Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Miconazole.
Abrocitinib
Major
The metabolism of Abrocitinib can be decreased when combined with Miconazole.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Miconazole.
Acetylsalicylic acid
Major
The metabolism of Acetylsalicylic acid can be decreased when combined with Miconazole.
Albendazole
Major
The metabolism of Albendazole can be decreased when combined with Miconazole.
Monistat Toxicity & Overdose RiskTaking too much miconazole may cause headaches, skin irritation, diarrhea, nausea, vomiting, stomach pain, and a change in taste. These symptoms can be managed with supportive care. The lowest toxic dose of miconazole in rats has been found to be 500mg/kg.
image of a doctor in a lab doing drug, clinical research

Monistat Novel Uses: Which Conditions Have a Clinical Trial Featuring Monistat?

203 active clinical trials are examining the potential of Monistat to reduce Dermatophytosis, Inflammation and Abnormal Sweating and Body Odor.
Condition
Clinical Trials
Trial Phases
Inflammation
59 Actively Recruiting
Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4
Yeast Infection
0 Actively Recruiting
Onychomycosis
0 Actively Recruiting
Acne Vulgaris
2 Actively Recruiting
Phase 1, Phase 2, Early Phase 1
Candidiasis
0 Actively Recruiting
Dermatitis, Seborrheic
0 Actively Recruiting
Dermatophytosis
0 Actively Recruiting
cutaneous candidiasis
0 Actively Recruiting
Cellulitis
0 Actively Recruiting
Tinea Versicolor
0 Actively Recruiting
Skin candida
0 Actively Recruiting
Tinea Pedis
0 Actively Recruiting
Arthrodermataceae
0 Actively Recruiting
Kerion Celsi
0 Actively Recruiting
Candidiasis, Vulvovaginal
0 Actively Recruiting
Tinea Cruris
0 Actively Recruiting
Tinea
0 Actively Recruiting
Intertrigo
0 Actively Recruiting
Oropharyngeal Candidiasis
0 Actively Recruiting
Ringworm
0 Actively Recruiting

Monistat Reviews: What are patients saying about Monistat?

5Patient Review
4/9/2011
Monistat for Yeast Infection of Vagina and Vulva
This treatment worked better than anything else I've ever used.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about monistat

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does MONISTAT take to work?

"You can expect MONISTAT® products to take up to 7 days to fully cure a yeast infection."

Answered by AI

What do you use MONISTAT for?

"This medication is used to treat vaginal yeast infections by reducing burning, itching, and discharge. It is an azole antifungal that works by stopping the growth of yeast that causes the infection."

Answered by AI

Does MONISTAT clear all yeast infections?

"If this is your first time experiencing a yeast infection, you should consult with a healthcare professional before using this product. The symptoms of a yeast infection can be similar to other conditions such as bacterial vaginosis or sexually transmitted infections. Monistat is only effective in treating fungal infections and not any other type of condition."

Answered by AI

What does MONISTAT do inside of you?

"The active ingredient in MONISTAT® products fights yeast and is applied inside the vagina to treat and cure the yeast infection. Most MONISTAT® products also come with external itch relief cream for relief of symptoms."

Answered by AI

Clinical Trials for Monistat

Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT
The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)
Waitlist Available
Has No Placebo
UConn HealthCutter Lindbergh, Ph.D.
Image of Department of Nutritional Sciences in Storrs, United States.

Freeze-dried Grape Powder for Healthy Aging

50 - 75
All Sexes
Storrs, CT
The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults. The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.
Recruiting
Paid Trial
Department of Nutritional Sciences
Have you considered Monistat clinical trials? We made a collection of clinical trials featuring Monistat, we think they might fit your search criteria.Go to Trials
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies
Phase 2
Recruiting
Abcentra Investigational Site (+6 Sites)Abcentra
Image of School of Public Health in Bloomington, United States.

High Salt Intake for High Blood Pressure

60 - 85
All Sexes
Bloomington, IN
Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury/impaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.
Recruiting
Has No Placebo
School of Public Health
Image of Tesla MedBed at Tampa-FL in Tampa, United States.

Biophoton Therapy for Stem Cell Proliferation

18 - 70
All Sexes
Tampa, FL
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.
Recruiting
Online Trial
Tesla MedBed at Tampa-FL (+1 Sites)James Z Liu, MD, PhD
Have you considered Monistat clinical trials? We made a collection of clinical trials featuring Monistat, we think they might fit your search criteria.Go to Trials
Image of UCSF in San Francisco, United States.

Moisturizers for Aging

65+
All Sexes
San Francisco, CA
This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.
Phase 4
Recruiting
UCSFKatrina Abuabara, MD
Have you considered Monistat clinical trials? We made a collection of clinical trials featuring Monistat, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security